plus, we are learning children are among the nearly 150 injured in a russian missile strike in ukraine. debt in coll, and no matter how much i paid, it followed me everywhere. the high interest. i i felt trapped. debt! debt! debt! debt! soso i broke up with my credit card debt and consolidated it into a low rate personal l loan from sofi. i finally feel like a grown-up. break up with bad credit card debt. get a personal loan with low fixed rates and borrow up to $100k. go to sofi.com to view your rate. sofi get your money right. drumroll by lónis, little league got the keys to what you want and whayou need somhing new something sweet moving to different beat okay now (what? can i get a (get a) drumroll (what?) can i get drumroll drumroll? (what?) can i get a can i get a drumroll please (oohh) that s nice (yahh) ya, can i get a drumroll, can i get a drum-
South Dakota Investment Council trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 11.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 248,972 shares of the specialty pharmaceutical company’s stock after selling 32,600 shares […]
investigating january 6 would eventually call it the final step in donald trump s plan to try and overturn the election, a plan that started in earnest with kenneth chesebro. and we re hearing from kenneth chesebro s attorney who told us last night he spoke to my coll colleague saying they re going to allow the legal process to play out and that they re declining to issue any public comment at this time. and that sort of has been chesebro s thing. he hasn t wanted to talk about it before the january 6th committee. he pleaded the fifth. he claimed attorney/client privilege for most of the interview. he is one of the people who is going to have to surrender in georgia next week by friday. great reporting, shion. i want to bring in elie honig. when you know kenneth chesebro s role in the federal and state cases, whether indicted or not, what s your take on what you
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 5,940,000 shares, a drop of 9.6% from the July 15th total of 6,570,000 shares. Currently, 17.6% of the company’s stock are short sold. […]
Gladius Capital Management LP cut its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 27.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,235 shares of the specialty pharmaceutical company’s stock after selling 478 shares during the […]